Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: Evidence of a sex difference? The Western New York experience

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 7, 2011, Pages 504-511

  Donahue, R P ^a   Dorn, J M ^a   Stranges, S ^a,b   Swanson, M ^a   Hovey, K ^a   Trevisan, M ^a,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF NEVADA   (United States)

Author keywords

Epidemiology; Follow up; Gender; Glucose; Population; Recurrent CVD

Indexed keywords

AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; QUESTIONNAIRE; RECURRENT DISEASE; RISK FACTOR; SEX DIFFERENCE; STROKE; SURVIVAL; UNITED STATES;

AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEW YORK; PREDIABETIC STATE; QUESTIONNAIRES; RECURRENCE; RISK FACTORS; SEX FACTORS; STROKE; SURVIVAL ANALYSIS;

EID: 79959498868     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.11.012     Document Type: Article

References (27)

1. Gu K., Cowie C.C., Harris M.I. Diabetes and decline in heart disease mortality in US adults. JAMA 1999, 281(14):1291-1297.
2. Gregg E.W., Gu Q., Cheng Y.J., Narayan K.M., Cowie C.C. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007, 147(3):149-155.
3. Abbott R.D., Donahue R.P., Kannel W.B., Wilson P.W. The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA 1988, 260(23):3456-3460.
4. Donahue R.P., Orchard T.J. Diabetes mellitus and macrovascular complications. An epidemiological perspective. Diabetes Care 1992, 15(9):1141-1155.
5. Levitzky Y.S., Pencina M.J., D'Agostino R.B., Meigs J.B., Murabito J.M., Vasan R.S., et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham heart study. J Am Coll Cardiol 2008, 51(3):264-270.
6. Koro C.E., Bowlin S.J., Rabatin V., Fedder D.O. Cardiovascular disease risk among subjects with impaired fasting glucose in the United States: results from NHANES 1999-2004. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2008, 2(4):239-244.
7. Hamsten A., Walldius G., Dahlen G., Johansson B., De Faire U. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis 1986, 59(2):223-235.
8. Genuth S., Alberti K.G., Bennett P. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
9. Donahue R.P., Goldberg R.J., Chen Z., Gore J.M., Alpert J.S. The influence of sex and diabetes mellitus on survival following acute myocardial infarction: a community-wide perspective. J Clin Epidemiol 1993, 46(3):245-252.
10. Behar S., Boyko V., Reicher-Reiss H., Goldbourt U. Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT study group. Secondary prevention reinfarction Israeli nifedipine trial. Am Heart J 1997, 133(3):290-296.
11. Donahue R.P., Bean J.A., Donahue R.D., Goldberg R.B., Prineas R.J. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami community health study. Arterioscler Thromb Vasc Biol 1997, 17(11):2413-2417.
12. Donahue R.P., Rejman K., Rafalson L.B., Dmochowski J., Stranges S., Trevisan M. Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York study. Diabetes Care 2007, 30(2):354-359.
13. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358(24):2545-2559.
14. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358(24):2560-2572.
15. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360(2):129-139.
16. Goodarzi M.O., Psaty B.M. Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate endpoint?. JAMA 2008, 300(17):2051-2053.
17. Bairey Merz C.N., Shaw L.J., Reis S.E., Bittner V., Kelsey S.F., Olson M., et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006, 47(3 Suppl):S21-S29.
18. Miettinen H., Lehto S., Salomaa V., Mahonen M., Niemela M., Haffner S.M., et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA myocardial infarction register study group. Diabetes Care 1998, 21(1):69-75.
19. Sprafka J.M., Burke G.L., Folsom A.R., McGovern P.G., Hahn L.P. Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey. Diabetes Care 1991, 14(7):537-543.
20. Shahar E., Folsom A.R., Jackson R. The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Atherosclerosis Risk in Communities (ARIC) study investigators. Ann Epidemiol 1996, 6(6):498-506.
21. Tell G.S., Fried L.P., Hermanson B., Manolio T.A., Newman A.B., Borhani N.O. Recruitment of adults 65 years and older as participants in the cardiovascular health study. Ann Epidemiol 1993, 3(4):358-366.
22. de Vegt F., Dekker J.M., Stehouwer C.D., Nijpels G., Bouter L.M., Heine R.J. The 1997 American diabetes association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn study. Diabetes Care. 1998, 21(10):1686-1690.
23. Feskens E.J., Bowles C.H., Kromhout D. Intra- and interindividual variability of glucose tolerance in an elderly population. J Clin Epidemiol 1991, 44(9):947-953.
24. McDonald G.W., Fisher G.F., Burnham C. Reproducibility of the oral glucose tolerance test. Diabetes 1965, 14:473-480.
25. Olefsky J.M., Reaven G.M. Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart. Diabetes 1974, 23(5):449-453.
26. McLaughlin T.J., Soumerai S.B., Willison D.J., Gurwitz J.H., Borbas C., Guadagnoli E., et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med 1996, 156(7):799-805.
27. Gottlieb S.S., McCarter R.J., Vogel R.A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998, 339(8):489-497.